Underestimation of the coexistence of iron deficiencies and thalassemia minors: a single institution experience in Taiwan  by Lin, Chung-King et al.
Kaohsiung Journal of Medical Sciences (2014) 30, 409e414Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comORIGINAL ARTICLEUnderestimation of the coexistence of iron
deficiencies and thalassemia minors: a single
institution experience in Taiwan
Chung-King Lin a,b,*, Ling-Ping Chen a,c, Hsiu-Lin Chang a,
Yung-Chuan Sung a,ca Division of Hematology-Oncology, Department of Internal Medicine, Cathay General
Hospital, Taipei, Taiwan
b Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical
University, Taipei, Taiwan
c Department of Internal Medicine, Medical College, Fujen Catholic University, Taipei,
TaiwanReceived 16 September 2013; accepted 19 March 2014







Thalassemia minorConflicts of interest: All authors d
* Corresponding author. Division of H
Section 4, Taipei 10630, Taiwan.
E-mail address: CKLinDM@gmail.co
http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2014, KaohsiuAbstract Some physicians neglect the possible coexistence of an iron deficiency with a thal-
assemia minor and do not treat the iron deficiency accordingly. This motivated us to conduct
this study. We retrospectively reviewed the records of 3892 patients who visited our clinics and
had hemoglobin (Hb) electrophoreses performed in our hematologic laboratory from August 1,
2007 to December 31, 2012. The thalassemia minors were identified by characteristic complete
blood count (CBC) parameters obtained from an autoanalyzer and Hb electrophoresis, and
some cases were confirmed with molecular tests. Then, we checked iron studies [ferritin
and/or serum iron with total iron-binding capacity (TIBC)] to determine the coexistence of
an iron deficiency with a thalassemia minor and a response to iron, if such treatments were
given. We found 792 cases with thalassemia minors, and excluded those without iron studies,
with 661 cases as our sample. A total of 202/661 cases (31%) also had iron deficiencies. They
had lower red blood cell (RBC) counts, Hb, and ferritin levels as compared to those thalassemia
minor cases without coexistence of iron deficiencies. We concluded that the thalassemia minor
patients did not have iron overload complications in our population. On the contrary, iron de-
ficiencies commonly coexist in the clinical visits. We propose that if Hb < 11.5 g/dL in a case of
thalassemia minor, one should screen for iron deficiency simultaneously. The sensitivity iseclare no conflicts of interest.
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MCV Z mean corpuscular volume;79.8% and the specificity is 82.6%. Therefore, physicians should be aware of this coexisting con-
dition, and know how to recognize and treat it accordingly.
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
The thalassemia syndromes are inherited disorders of
globin synthesis. Thalassemia has a wide spectrum of
manifestations, ranging from an asymptomatic nature to
severe disease requiring frequent packed red cell trans-
fusions [1]. Iron overload is a common complication in
thalassemia major and intermedia [2,3]. Thalassemia minor
is a carrier state in which only one allele is mutated. It has
been debated as to whether b-thalassemia minor has
increased iron absorption [4,5]. From our experience, we
found that iron deficiencies commonly occur with thalas-
semia minors. Because the symptoms and signs of iron
deficiency resemble those of anemia and the blood picture
is similar to thalassemia itself, the simultaneous prevalencetrating inclusion and exclusion
RBC Z red blood cell; TIBC Z tof iron deficiency in these people is often overlooked. In
particular, many non-hematologist physicians may neglect
this coexistence and leave an iron deficiency untreated [6].
As such, the anemia could become severe enough to affect
normal activities. Furthermore, physicians could miss hints
of other potential underlying diagnoses, such as malig-
nancies. This motivated us to conduct this study.Methods
Study participants
We retrieved all of the records on those patients who had
hemoglobin (Hb) electrophoreses performed at ourcriteria. Fe Z iron; Hb Z hemoglobin; ID Z iron deficiency;
otal iron-binding capacity.
Table 1 Pure thalassemia (a and b) versus thalassemia plus iron deficiency (ID).
Parameter Pure thalassemia (n Z 259) Thalassemia plus ID (n Z 198)
Mean SD Range Mean SD Range p
Hb (g/dL) 12.8 1.4 9.7e16.0 9.8 1.9 3.4e15.1 <0.001
MCV (fL) 65.1 4.6 48.7e78.7 62.1 6.7 47.1e78.8 <0.001
RBC (106/mL) 6.0 0.6 4.0e9.0 5.2 0.7 3.2e6.5 <0.001
RDW-CV (%) 16.0 1.7 13.3e23.2 18.2 3.3 14.1e32.3 <0.001
A2 (%) 3.6 1.7 1.0e8.3 2.8 1.3 1.0e6.5 <0.001
Ferritin (ng/dL) 205.5 129.5 30.5e760.0 22.3 42.8 0.6e362.0 <0.001
A2Z Hemoglobin A2; HbZ hemoglobin; MCVZmean corpuscular volume; RBCZ red blood cell; RDW-CVZ red cell distribution width-
coefficient of variations; SD Z standard deviation.
Co-occurrence of an iron deficiency in a thalassemia minor 411hospital, a tertiary medical center in Taiwan, from August
1, 2007 to December 31, 2012; this resulted in a total of
3892 cases, including a few from routine check-ups (Fig. 1).
We confirmed the diagnoses of thalassemia minors by
complete blood count (CBC) indices, Hb electrophoreses,
and confirmed some with molecular tests. Then, we
checked their iron studies, serum ferritin and/or serum iron
(Fe) with total iron-binding capacity (TIBC), to confirm the
diagnosis of iron deficiency. We excluded those younger
than 2 years of age (due to the possible effect of HbF
quantitation) and those without iron studies; hematologists
confirmed the diagnoses. In particular, those with a-thal-
assemia minor combined with iron deficiency had CBC
panels performed prior to, during, and after an iron treat-
ment. To be diagnosed with a-thalassemia minor, the mean
corpuscular volume (MCV) was <80 fL, the red blood cell
(RBC) count (in 106/mL)/Hb (in g/dL) ratio [7] was >0.4 and
the Mentrer index (MCV in fL/RBC in 106/mL) was <14 [8].
One of the CBC panels (before iron deficiency developed or
improved after iron treatment) fit these criteria. Their Hb
electrophoresis was normal. The diagnosis of b-thalassemia
minor complexes was supported by characteristic CBC pa-
rameters, as well as by Hb electrophoresis, with an
elevated HbA2 level (>4%) and/or HbF level (>1%). The
diagnosis of iron deficiency was defined by a low ferritin
level (30 ng/dL in males and 20 ng/dL in females) and/
or low transferrin saturation (15%) if the TIBC was high or
normal [9]. In cases whose ferritin levels were in the
indeterminate zone (a ferritin level >20 ng/dL in females
or >30 ng/dL in males, but <100 ng/dL in both sexes), then
they must have responses to iron treatments, as demon-
strated by a series of CBC panels (Fig. 1).Table 2 Data comparison between separate thalassemia and th
Parameter a-Thalassemia
Without ID (n Z 154) With ID (n Z 146)
Hb (g/dL) 13.2  1.3 10.0  1.9 <0
MCV (fL) 66.6  3.6 62.5  6.6 <0
RBC (106/mL) 6.1  0.6 5.3  0.6 <0
RDW (%) 15.8  1.8 18.1  3.5 <0
A2 (%) 2.3  0.4 2.2  0.4 0
A2 Z Hemoglobin A2; Hb Z hemoglobin; MCV Z mean corpuscular vo
SD Z standard deviation.Laboratory methods
CBC indices were obtained by the XE-2100 Sysmex auto-
analyzer (Sysmex, Kakogawa, Japan) [10]. In the period
after May 26, 2011, Hb electrophoresis by using the capil-
lary electrophoresis method [7,11] was performed with the
Minicap Hemoglobin kit (Sebia, Lisses, Everycedex, France)
in an alkaline buffer (pH 9.4). In the period prior to May 26,
2011, it was performed by Helena’s Hemoglobin Electro-
phoresis (Helena France, St. Leu La Foret, France) [12]
using cellulose acetate in an alkaline buffer (pH 8.2e8.6).
Molecular analyses of a-globin genes were performed by
the polymerase chain reaction (PCR) method, to detect the
Southeast Asia deletion [13,14]. The restriction fragment
length polymorphisms of the PCR product for the b-globin
gene mutation were confirmed by testing for the four most
common changes in our population: codon 41e42, IVS-2
nt654, codon 17 (b0), and 28 (bþ) [15e17]. Serum
ferritin determination and determinations of serum Fe and
unsaturated IBC were all measured by standard procedures
[18,19].Statistical analysis
Student t tests were used to compare continuous variables
in different groups. Sensitivity, specificity, positive pre-
dictive value (PPV), and negative predictive value (NPV)
were defined as follows: sensitivity Z true positives/(true
positives þ false negatives), specificity Z true negatives/
(true negatives þ false positives), PPV Z true positives/
total number of test positives, NPV Z true negatives/totalalassemia plus iron deficiency (ID).
b-Thalassemia
p Without ID (n Z 105) With ID (n Z 52) p
.001 12.1  1.2 9.3  2.0 <0.001
.001 62.8  5.1 60.8  6.8 0.071
.001 5.9  0.7 5.0  0.8 <0.001
.001 16.3  1.6 18.4  2.7 0.013
.046 5.4  1.2 4.5  1.5 <0.001
lume; RBC Z red blood cell; RDW Z red cell distribution width;
Table 3 Data comparison between a- and b-thalassemia without coexisting iron deficiency (ID).
Parameter Pure a-thalassemia (n Z 154) Pure b-thalassemia (n Z 105)
Mean SD Range Mean SD Range p
Hb (g/dL) 13.2 1.3 9.7e16.0 12.1 1.2 9.9e15.6 <0.001
MCV (fL) 66.6 3.6 48.7e76.8 62.8 5.1 53.7e78.7 <0.001
RBC (106/mL) 6.1 0.6 4.89.0 5.9 0.7 4.0e7.5 0.012
RDW (%) 15.8 1.8 13.4e23.2 16.3 1.6 13.3e26.2 0.224
A2 (%) 2.3 0.4 1.3e3.2 5.4 1.2 1.0e8.3 <0.001
Ferritin (ng/dL) 195.9 133.6 30.5e760.0 219.9 122.3 41.9e638.0 0.153
A2 Z Hemoglobin A2; Hb Z hemoglobin; MCV Z mean corpuscular volume; RBC Z red blood cell; RDW Z red cell distribution width;
SD Z standard deviation.
412 C.-K. Lin et al.number of test negatives. All p values < 0.05 were defined
as statistically significant. Statistical analyses were per-
formed using SPSS version 12 for windows (SPSS Inc., Chi-
cago, IL, USA).Results
A total of 3892 cases were reviewed (Fig. 1). We identified
792 cases, of which 498 had a-thalassemia minor and 294
had b-thalassemia minor (307 males and 485 females; aged
2e92 years; median, 33 years). We excluded those younger
than 2 years of age and those without iron studies; a total
of 661 cases remained (224 males, 437 females, 423 a-
thalassemia minors and 238 b-thalassemia minors). Thirty-
one percent of patients (202 cases) also had combined
iron deficiencies (149 a-thalassemia minors and 53 b-thal-
assemia minors; 27 males and 175 females; aged 2e92
years; median, 34 years). The combination was present in
12% of males and 40% of females; the difference was sig-
nificant (p < 0.001). We excluded those with the potential
for combined anemia of chronic diseases and borderline
iron deficiencies, leaving 457 cases for more meaningful
data comparisons (Fig. 1).
We found that the thalassemia patients who had co-
occurrence of iron deficiencies had lower Hb (9.8 g/dL vs.
12.8 g /dL) and RBC counts (5.2  106/mL vs. 6.0  106/mL),
compared to those patients who did not have any iron de-
ficiencies (Table1). The combined patients’ red cellTable 4 Sensitivity, specificity, positive predictive value
(PPV) and negative predictive value (NPV) under different









11.1 72.2 88.8 83.1 80.7
11.2 75.6 87.3 82.0 82.5
11.3 77.3 85.7 80.5 83.1
11.4 78.3 84.9 79.9 83.7
11.5 79.8 82.6 77.8 82.6
11.6 81.8 79.9 75.7 85.2
11.7 82.8 76.1 72.6 85.3
11.8 84.3 73.4 70.8 86.0
11.9 86.4 70.3 69.0 87.1
12.0 87.9 69.1 68.5 88.2distribution width-coefficient of variations (RDW-CV) were
wider (18.2% vs. 16.0%). The MCV were smaller in the a-
thalassemia patients who had co-occurrence of iron de-
ficiencies (62.5 vs. 66.6 fL) then those without; but the
difference were not present in b-thalassemia minor pa-
tients (Table 2). As suspected, their ferritin levels were
lower (22 ng/dL vs. 206 ng/dL), confirming the diagnosis of
iron deficiencies (Table 1). The thalassemia minors com-
bined with iron deficiencies had lower HbA2 (2.8% vs. 3.6 %)
determinations (Tables 1 and 2). Comparing the group
without coexisting iron deficiencies, pure b-thalassemia
minor patients had lower Hb (12.1 g/dL vs. 13.2 g/dL) and
MCV (63 fL vs. 67 fL), but not lower RBC counts as compared
to pure a-thalassemia minor patients (Table 3). Using
11.5 g/dL as a cutoff point, the sensitivity was 79.8% and
the specificity was 82.6%. The PPV was 77.8% and the NPV
was 82.6% (Table 4 and Fig. 2).
Discussion
Few publications in the past have addressed the co-
existence of b-thalassemia minor and iron deficiencies
[5,20], but not a-thalassemia minor, as in our study. DolaiFigure 2. Sensitivity and specificity in different cutoff values
of Hb (g/dL) to detect the coexistence of iron deficiencies and
thalassemia minors.
Co-occurrence of an iron deficiency in a thalassemia minor 413et al. [5] concluded that iron deficiency is one of the
common co-existing conditions in b-thalassemia minors in
India. Economidou et al. [20] had a similar finding in 61% of
non-pregnant and 32% of pregnant female b-thalassemia
minors in Greece. In our population, the incidence rate of
thalassemia minor was around 5e7% (for a-thalassemia
minor, 4e5%; for b-thalassemia minor, 1e2%), as seen in
previous studies [21e24]. Iron overload was seen in nearly
every case of b-thalassemia major or intermedia [2] and in
some of Hb H diseases [3,25]. Nevertheless, primary he-
mochromatosis was rarely seen in our population [26]. By
contrast, iron deficiency accounts for about half of the
world’s anemia burden. The World Health Organization
estimated that in 2004, iron deficiency anemia resulted in
273,000 deaths in the world. Among these, 45% were in
Southeast Asia [27]. According to a general population
study in Taiwan (1993e1995), iron deficiency was found in
2.1% of males and 10.7% of females [28]. The co-occurrence
rate of iron deficiencies and thalassemia minors was 31% in
our hospital clinic, which does not apply to the general
population; this is a figure that could not be neglected.
After analyzing different cutoff point values, we favored
using Hb 11.5 g/dL. If Hb< 11.5 g/dL in a case of thalassemia
minor, the combination of iron deficiencies or other condi-
tions should be evaluated. The NPVand specificity were both
82.6% (Table 4 and Fig. 2). Burdick addressed a letter to the
editor of the American Journal of Clinical pathology in 2009
[29], suggesting a cutoff value of 11 g/dL. Because a thal-
assemia minor rarely causes this degree of anemia, if its RBC
count is lower than 5 106/mL and RDW-CV is>17%. Thismay
bemore appropriate in a female thalassemiaminor, as in our
data (not shown). He found that exactly one third of patients
with microcytic anemia and thalassemia minor also had iron
deficiency (C. Burdick, unpublished).
We excluded thalassemia minima because the condition
would not be detected by an MCV < 80 fL, as in our study
[1]. Heterozygous gdb-thalassemia minor cannot be diag-
nosed by Hb electrophoresis and could be misdiagnosed as
a-thalassemia; however, this condition is very rare [1].
From previous studies and also shown in our study, it is
known that an iron deficiency can lower the HbA2 level
(Tables 1 and 2) and can affect the screening for a b-thal-
assemia [30]. However, this issue did not influence our
study, because we were not studying the incidence of
thalassemia minor. Instead, we studied the crude co-
occurrence rate of iron deficiencies with thalassemia mi-
nors. We used stricter criteria of HbA2 > 4% [31,32] and/or
Hb F > 1% in a population aged 2 years and older to di-
agnose the b-thalassemia minor complex, which could
include persistence of Hb F [1]. For a diagnosis of a-thal-
assemia minor, which was suspected with a low MCV < 80 fL
and a relatively high RBC count [6,33], the RBC/Hb [7] must
be >0.4 and fit the Mentrer index (MCV/RBC < 14) [8]. Hb
electrophoreses would be within normal limits. In a case
with a combined iron deficiency, at least one of the CBC
parameters would fit the above criteria, prior to, during, or
after an iron treatment. We also excluded the possibility of
combined a- and b-thalassemia minors when there were no
molecular studies to support the combination [34]. Actu-
ally, the majority had no molecular tests to confirm the
diagnoses of thalassemia minors, which is the major limi-
tation of this study.In conclusion, we did not see iron overload in thalas-
semia minor patients. On the contrary, we emphasize that
the combination of an iron deficiency and a thalassemia
minor is not uncommon, especially in those patients who
visited hospital clinics. We recommend that if Hb
is < 11.5 g/dL in a case of thalassemia minor, the combi-
nation of iron deficiency or other conditions should be
evaluated. The differentiation of a thalassemia minor from
an iron deficiency (which can be confused by some physi-
cians) and the possibility of the two conditions combined
should be known, to enable physicians to recognize and
treat it accordingly.Acknowledgments
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